Filing Details

Accession Number:
0001562180-22-006076
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-08-12 19:49:40
Reporting Period:
2022-08-10
Accepted Time:
2022-08-12 19:49:40
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1603756 Axonics Inc. AXNX Surgical & Medical Instruments & Apparatus (3841) 454744083
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1756437 John Woock 26 Technology Drive
Irvine CA 92618
Chief Marketing Officer No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-08-10 7,500 $1.63 68,476 No 4 M Direct
Common Stock Disposition 2022-08-10 9,151 $69.46 59,325 No 4 S Direct
Common Stock Disposition 2022-08-10 5,849 $70.10 53,476 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2022-08-10 7,500 $0.00 7,500 $1.63
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
3,700 2028-03-30 No 4 M Direct
Footnotes
  1. This sale was pursuant to a 10b5-1 plan adopted by the reporting person.
  2. This transaction was executed in multiple trades at prices ranging from $69.02 to $70.01. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  3. This transaction was executed in multiple trades at prices ranging from $70.02 to $70.28. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  4. The shares subject to the option vest over a period of four years. 7,800 of the shares subject to the option vested on March 30, 2018 and the remainder vest at a rate of 1/36th per month commencing on March 30, 2019, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including upon certain changes of control of the Issuer. The option is subject to an early exercise provision and is immediately exercisable.